RECONESIS was established to support research institutes/researchers
in a wide range of medical/biological/chemical areas by providing
them with its unique knowledge and technologies, and to help them
become successful in global-scale competition.
RECONESIS can help small- and medium-sized pharmaceutical and
biotech companies by performing contract research and/or consulting
relating to peptide design and computational chemistry/biology
without requiring a share of their intellectual property rights.
RECONESIS's representative has an extensive education/research
history. This will benefit non-native English speaking researchers
going through the lengthy processes involved in paper publication.